Epoetin alfa in patients not on chemotherapy - Canadian data

Seminars in Oncology

Volumn 29, Issue 3 SUPPL. 8, 2002, Pages 75-80

  Quirt, Ian ^a   Robeson, Christine ^a   Lau, Cathy Y ^a   Kovacs, Michael ^a   Burdette Radoux, Susan ^a   Dolan, Sean ^a   Tang, Shou Ching ^a   McKenzie, Michael ^a   Couture, Felix ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b Janssen Ortho Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; CANADA; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FUNCTIONAL ASSESSMENT; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; STATISTICAL ANALYSIS;

EID: 0036288097     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0093-7754(02)70178-4     Document Type: Conference Paper

References (16)

1. Anemia of cancer
2. Clinical guidelines for the treatment of cancer-related anemia
3. Progress toward guidelines for the management of fatigue
4. Cancer-related fatigue: Guidelines for evaluation and management
5. Characterization and biological effects of recombinant human erythropoietin
6. Recombinant human erythropoietin in the treatment of the anaemia of cancer
7. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies
8. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
9. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
10. Clinical applications of visual analog scales: A critical review
11. Assessment of the quality of life of patients with advanced cancer
12. Sensitivity and accuracy of the visual analog scale: A psychophysical classroom experiment
13. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
14. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
15. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
16. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy